Increased use may not be a major reason U.S. opioid overdose deaths have fallen since 2023. Brown University reported a study comparing Naloxone use with overdose numbers. This medicine can quickly reverse an opioid overdose. Researchers looked at use as overdose deaths fell across the country. They also examined use by people nearby, including friends and family members. The key was comparing medicine use with the number of overdoses. Fewer overdoses would naturally mean fewer people needing the medicine. So a drop in total use alone would not explain much. After accounting for fewer overdoses, use stayed at nearly the same rate. Use by friends, family, and other bystanders was 28.6% lower than expected from earlier trends. That gap remained even after accounting for the decline in overdoses. It was not a measure of how well the medicine worked. These findings suggest fewer overdoses may help explain the decline in deaths. Increased use of the rescue medicine may not be a main driver. But the report does not establish why overdoses have fallen. It also does not show that Naloxone has stopped saving lives. For BioSocial members, this is a useful distinction: carrying medicine differs from needing it. Personal tracking could capture how often it is available when away from home. Comparing notes could reveal shared barriers to keeping it nearby. Those experiences add context, but they cannot explain a national trend on their own. What has shaped your experience of keeping Naloxone available for yourself or others?